Rekombinanter IL23A (Mirikizumab Biosimilar) Antikörper
Research Grade
Reaktivität: Human
ELISA
Wirt: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target
- IL23A (Mirikizumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
- Wirt
-
Mammalian Cells
- Expressionssystem
- Mammalian cells
- Klonalität
- Monoklonal
- Applikation
- ELISA
- Verwendungszweck
- Mirikizumab Biosimilar - Anti-IL23A mAb
- Produktmerkmale
- Antibody Type: IgG4-kappa
- Aufreinigung
- Recombinant antibody expressed in mammalien cells and purified.
- Güteklasse
- Research Grade
- Isotyp
- IgG4 kappa
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS pH 7.5
- Lagerung
- -80 °C
- Informationen zur Lagerung
- store at -80°C
-
- Target
- IL23A (Mirikizumab Biosimilar)
- Substanzklasse
- Biosimilar
- Hintergrund
-
LY-3074828
Mirikizumab is a humanized IgG4 monoclonal antibody that targets p19 subunit of IL-23. Currently, mirikizumab is being developed for a variety of immune diseases, including psoriasis, UC, and Crohn's disease (CD). - CAS-Nummer
- 1884201-71-1
-
Sie sind hier:
